P
Pliant Therapeutics, Inc. (PLRX)
NMS – Real Time Price. Currency in USD
1.14
+0.01 (0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.15
+0.01 (0.67%)
After-hours: Jun 26, 2026, 7:23 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.14
+0.01 (0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.15
+0.01 (0.67%)
After-hours: Jun 26, 2026, 7:23 PM EDT
No Data
There are no news for this stock.
Total debt $28.8M significantly exceeds cash reserves ($22.2M), raising financial stability concerns
Total current assets $174.9M exceed Total current liabilities $10.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$19.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.89 | 6.05 | 10 | |
| Quick ratio | 16.89 | 5.63 | 10 | |
| Debt to Equity | 0.17 | 0.30 | 9.0 | |
| Debt to Assets | 0.14 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 10M | 2M | N/A | N/A | N/A |
| Gross Profit | 6M | -261K | -2M | -2M | -2M |
| Operating Income | -127M | -184M | -228M | -150M | -117M |
| Net Income | -123M | -161M | -210M | -149M | -113M |
| EBITDA | -124M | -182M | -226M | -148M | -115M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 51.67 | 5.5 |
| Next quarter | N/A | 15.25 | 5.0 |
| Current year | N/A | 42.05 | 5.5 |
| Next year | N/A | 25.19 | 5.5 |
| Weighted average score | 5.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 15 | 15.79 | -8.09 | 7.0 |
| Y/Y | 999 | 64.32 | 65.22 | 60.86 | 10 |
| 3y average | 271.78 | -10.71 | 3.42 | -12.75 | 4.0 |
| 5y average | 152.27 | -38.61 | -7.43 | -32.44 | 3.3 |
| Weighted average score | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |